Paul A. Bunn, Jr., MD
James Dudley Chair in Cancer Research
Professor, Medical Oncology
University of Colorado Denver
Aurora, CO
Executive Director, International Association for the Study of Lung Cancer
(IASLC)

Roy S. Herbst, MD, PhD
Chief, Section of Thoracic Oncology
Professor of Medicine & Cancer Biology
Department of Thoracic / Head & Neck Medical Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Corey J. Langer, MD
Professor of Medicine
Director, Thoracic Oncology
Division of Hematology-Oncology
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA
Vice Chair, Radiation Therapy Oncology Group
(RTOG)

Walter J. Curran, MD, FACR
Professor and Chair
Department of Radiation Oncology
Emory School of Medicine Chief Medical Officer
Winship Cancer Institute
Atlanta, GA
Chairman, Radiation Therapy Oncology Group
(RTOG)

Edward B. Garon, MD
 

Barbara J. Gitlitz, MD
 

Fairooz F. Kabbinavar, MD
 

Mark G. Kris, MD
Chief, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan-Kettering Cancer Center
New York, NY

Thomas J. Lynch, MD
Chief, Division of Hematology and Oncology
Director, Center for Thoracic Cancer
Massachusetts General Hospital
Cancer Center
Boston, MA

Ignacio I. Wistuba, MD
 

Taught by the top academic experts in lung cancer and head & neck cancer this is THE symposium on lung cancer and head & neck cancer that you should attend in 2010. It contains the most up-to-date data from the recent ASCO meeting. This symposium will help clinicians improve their selection of the most appropriate therapeutics, and will also help clinicians to identify the patient sub-populations of lung cancer and head & neck cancer who will respond to specific drug therapies.